First-trimester Down syndrome screening: Free β-human chorionic gonadotropin and pregnancy-associated plasma protein A

American Journal of Obstetrics and Gynecology

Volumn 174, Issue 2, 1996, Pages 612-616

  Krantz, D A ^a   Larsen, J W ^a   Buchanan, P D ^a   Macri, J N ^a  

^a NTD Laboratories Inc ^*  (United States)

Author keywords

Down syndrome; first trimester; free human chorionic gonadotropin; maternal serum screening; pregnancy associated plasma protein A

Indexed keywords

ALPHA FETOPROTEIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; ESTRIOL; PREGNANCY ASSOCIATED PLASMA PROTEIN A;

ARTICLE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FIRST TRIMESTER PREGNANCY; GENETIC SCREENING; GESTATIONAL AGE; HUMAN; PRENATAL DIAGNOSIS; PRIORITY JOURNAL;

EID: 0030027891     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(96)70436-2     Document Type: Article

References (25)

1. IR Merkatz HM Nitowski JN Macri WE Johnson An association between low maternal serum α-fetoprotein and fetal chromosome abnormalities AM J OBSTET GYNECOL 148 1984 886 894
2. HM Bogart MR Pandian OW. Jones Abnormal maternal serum chorionic gonadotropin levels in pregnancies with fetal chromosome abnormalities Prenat Diagn 7 1987 623 630
3. JN Macri RV Kasturi DA Krantz Maternal serum Down syndrome screening: free β-protein is a more effective marker than human chorionic gonadotropin AM J OBSTET GYNECOL 163 1990 1248 1253
4. NJ Wald A Kennard JW Densem HS Cuckle T Chard L Butler Antenatal maternal serum screening for Down's syndrome: results of a demonstration project BMJ 305 1992 391 394
5. K Spencer P Carpenter Prospective study of prenatal screening for Down's syndrome with free beta human chorionic gonadotropin BMJ 307 1993 764 769
6. JN Macri K Spencer K Garver Maternal serum free beta hCG screening: results of studies including 480 cases of Down syndrome Prenat Diagn 14 1994 97 103
7. HS Cuckle NJ Wald G Barkai W Fuhrmann K Altland B. Brambati First trimester biochemical screening for Down syndrome Lancet 2 1988 851 852
8. DJH Brock L Baron S Holloway WA Liston SG Hillier M. Seppala First trimester maternal serum biochemical indicators in Down syndrome Prenat Diagn 10 1990 245 251
9. van Lith Dutch Working Party on Prenatal Diagnosis First-trimester maternal serum human chorionic gonadotrophin as a marker for fetal chromosome disorders Prenat Diagn 12 1992 495 504
10. DA Aitken G Mccaw JA Crossley First trimester biochemical screening for fetal chromosome abnormalities and neural tube defects Prenat Diagn 13 1993 681 689
11. BF Crandall FW Hanson S Keener M Matsumoto W Miller Maternal serum screening for α-fetoprotein, unconjugated estriol, and human chorionic gonadotropin between 11 and 15 weeks of pregnancy to detect fetal chromosome abnormalities AM J OBSTET GYNECOL 168 1993 1864 1869
12. MCM Macintosh R Iles B Teisner Maternal serum human chorionic gonadotrophin and pregnancy-associated plasma protein A, markers for fetal Down syndrome at 8-14 weeks Prenat Diagn 14 1994 203 208
13. JN Macri K Spencer D Aitken First trimester free beta (hCG) screening for Down syndrome Prenat Diagn 13 1993 557 562
14. B Brambati MCM Macintosh B Teisner Low maternal serum levels of pregnancy-associated plasma protein A (PAPP-A) in the first trimester in association with abnormal fetal karyotype Br J Obstet Gynaecol 100 1993 324 326
15. N Wald R Stone HS Cuckle First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down's syndrome BMJ 305 1992 28
16. F Muller H Cuckle B Teisner G. Grudzinskis Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy Prenat Diagn 13 1993 633 636
17. K Spencer DA Aitken JA Crossley First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha-fetoprotein and pregnancy associated plasma protein A Ann Clin Biochem 31 1994 447 454
18. ML Brizot RJM Snijders NA Bersinger P Kuhn KH. Nicolaides Maternal serum pregnancy associated plasma protein A and fetal nuchal translucency thickness for the prediction of fetal trisomies in early pregnancy Obstet Gynecol 84 1994 918 922
19. NA Bersinger ML Brizot A Johnson First trimester maternal serum pregnancy-associated plasma protein A and pregnancy-specific beta 1-glycoprotein in fetal trisomies Br J Obstet Gynaecol 101 1994 970 974
20. B Brambati L Tului I Bonacchi K Shrimaker Y Suzuki JG. Grudzinskas Serum PAPP-A and free beta hCG are first trimester screening markers for Down syndrome Prenat Diagn 14 1994 1043 1047
21. JN Macri K Spencer RW Anderson EJ. Cook Free beta chorionic gonadotropin: a cross-reactivity study of two immunometric assays used in prenatal maternal serum screening for Down syndrome Ann Clin Biochem 30 1993 94 98
22. EB Hook GM. Chambers Numerical taxonome on birth defects and polygenic disorders D Bergsma RB Lowry BK Trimble M Feingold Birth defects, original article series 8 1977 Alan R Liss New York 123 141
23. E Berry DA Aitken JA Crossley JN Macri MJ Connor Analysis of maternal serum alpha-fetoprotein and free beta human chorionic gonadotrophin in the first trimester: implications for Down's syndrome screening Prenat Diagn 15 1995 555 565
24. MCM Macintosh T Chard Biochemical screening for Down's syndrome in the first trimester of pregnancy Fetal Matern Med Rev 5 1993 181 190
25. KH Nicolaides ML Brizot RJM. Snijders Fetal nuchal translucency: ultrasound screening for fetal trisomy in the first trimester of pregnancy Br J Obstet Gynaecol 101 1994 782 786